Medication info

Rotagen Tablet 50 Milligrams (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
IQUR Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603172 · Approved 2016.06.02

Summary

Main use
Treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This medication may be taken regardless of meals, but it is recommended to take it at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to a maximum of 100 mg once daily. If blood pressure is not controlled with this medication alone, it may be administered concomitantly with another antihypertensive medication (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medication once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medication may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medication once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medication once daily is recommended. Patients with reduced intravascular effective blood volume An initial dose of 25 mg of this medication once daily is recommended for patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). Patients with hepatic impairment Consider administering a low dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medication once daily; it may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medication once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
IQUR Co., Ltd.

Efficacy & effects

Treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used to treat high blood pressure. It also helps to slow the progression of kidney disease in patients with high blood pressure and type 2 diabetes. Therefore, it is effective for the prevention and treatment of complications associated with high blood pressure.

How to take

Adult dose

This medication may be taken regardless of meals, but it is recommended to take it at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to a maximum of 100 mg once daily. If blood pressure is not controlled with this medication alone, it may be administered concomitantly with another antihypertensive medication (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medication once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medication may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medication once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medication once daily is recommended. Patients with reduced intravascular effective blood volume An initial dose of 25 mg of this medication once daily is recommended for patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). Patients with hepatic impairment Consider administering a low dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medication once daily; it may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medication once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, women who are pregnant or may become pregnant should not take it. Patients with allergies to this drug, severely impaired liver function, certain genetic diseases, and primary hyperaldosteronism should not use it. Caution should be exercised in elderly patients, patients with hyperkalemia, patients with impaired liver or kidney function, and patients with heart valve disease or ischemic heart disease. This drug lowers blood pressure, potentially leading to serious side effects such as hypotension and renal failure, so regular monitoring of blood pressure and kidney function is necessary. During treatment, it is advisable not to use potassium supplements, potassium-containing salt substitutes, or potassium-sparing diuretics, and to avoid grapefruit juice. Angioedema, which causes swelling of the face, lips, or tongue, may occasionally occur, so immediate consultation with healthcare professionals is necessary if such symptoms arise. Side effects may include dizziness, drowsiness, cough, dyspepsia, and muscle pain; if symptoms are severe, consult a doctor. It is advisable for pregnant or nursing women to avoid this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately and healthcare professionals should be consulted. This drug should not be administered to children, especially those under 6 years of age or those with significantly impaired kidney function. In case of overdose, hypotension and abnormal heart rate may occur, and immediate hospital treatment is required. This drug should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 127 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • stroke
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • reduced libido
  • memory impairment
  • migraine
  • neurogenic hypersensitivity
  • paresthesia
  • polyneuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • skin dryness
  • purpura
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • increased urination
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • creatine kinase elevation
  • rhabdomyolysis
  • dry cough
  • erythroderma
  • hyponatremia
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia
  • shock symptoms due to hypotension
  • loss of consciousness due to hypotension
  • dyspnea due to hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to avoid exposure to air and moisture and is best stored at room temperature between 1°C and 30°C. Storing it this way helps maintain the drug's effectiveness safely.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.